(S)-4-Benzyl-2-oxazolidinoneCAS# 90719-32-7 |
2D Structure
- (R)-4-Benzyl-2-oxazolidinone
Catalog No.:BCC8395
CAS No.:102029-44-7
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 90719-32-7 | SDF | Download SDF |
PubChem ID | 736225 | Appearance | Powder |
Formula | C10H11NO2 | M.Wt | 177 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (4S)-4-benzyl-1,3-oxazolidin-2-one | ||
SMILES | C1C(NC(=O)O1)CC2=CC=CC=C2 | ||
Standard InChIKey | OJOFMLDBXPDXLQ-VIFPVBQESA-N | ||
Standard InChI | InChI=1S/C10H11NO2/c12-10-11-9(7-13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12)/t9-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
(S)-4-Benzyl-2-oxazolidinone Dilution Calculator
(S)-4-Benzyl-2-oxazolidinone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.6497 mL | 28.2486 mL | 56.4972 mL | 112.9944 mL | 141.2429 mL |
5 mM | 1.1299 mL | 5.6497 mL | 11.2994 mL | 22.5989 mL | 28.2486 mL |
10 mM | 0.565 mL | 2.8249 mL | 5.6497 mL | 11.2994 mL | 14.1243 mL |
50 mM | 0.113 mL | 0.565 mL | 1.1299 mL | 2.2599 mL | 2.8249 mL |
100 mM | 0.0565 mL | 0.2825 mL | 0.565 mL | 1.1299 mL | 1.4124 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ethyl beta-carboline-1-propionate
Catalog No.:BCN1311
CAS No.:90686-24-1
- 5-Hydroxysophoranone
Catalog No.:BCN6842
CAS No.:90686-12-7
- Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate
Catalog No.:BCN7597
CAS No.:90685-26-0
- SCH 546738
Catalog No.:BCC4110
CAS No.:906805-42-3
- Parvifolixanthone B
Catalog No.:BCN7421
CAS No.:906794-57-8
- Parvifolixanthone A
Catalog No.:BCN7354
CAS No.:906794-56-7
- AN-2728
Catalog No.:BCC1361
CAS No.:906673-24-3
- Teneligliptin hydrobromide
Catalog No.:BCC1992
CAS No.:906093-29-6
- Neochlorogenic acid
Catalog No.:BCN4450
CAS No.:906-33-2
- CGK733
Catalog No.:BCC3911
CAS No.:905973-89-9
- Isopsoralenoside
Catalog No.:BCN3197
CAS No.:905954-18-9
- Psoralenoside
Catalog No.:BCN3196
CAS No.:905954-17-8
- Musellactone
Catalog No.:BCN7183
CAS No.:907583-51-1
- Atosiban
Catalog No.:BCC5314
CAS No.:90779-69-4
- 6,8-Di-O-methylcitreoisocoumarin
Catalog No.:BCN7380
CAS No.:908098-80-6
- SNX-2112
Catalog No.:BCC2132
CAS No.:908112-43-6
- PF-04929113 (SNX-5422)
Catalog No.:BCC2130
CAS No.:908115-27-5
- Cyclo(Ile-Ala)
Catalog No.:BCN2429
CAS No.:90821-99-1
- Goshonoside F1
Catalog No.:BCN6444
CAS No.:90851-24-4
- Goshonoside F5
Catalog No.:BCN6442
CAS No.:90851-28-8
- ent-Labda-8(17),13E-diene-3beta,15,18-triol
Catalog No.:BCN7662
CAS No.:90851-50-6
- Ptelatoside B
Catalog No.:BCN4451
CAS No.:90852-99-6
- Aprotinin
Catalog No.:BCC1220
CAS No.:9087-70-1
- α-helical CRF 9-41
Catalog No.:BCC5727
CAS No.:90880-23-2
Stereoselective total synthesis of (+)-licochalcone E.[Pubmed:21910047]
Arch Pharm Res. 2011 Aug;34(8):1269-76.
The synthesis of (+)-licochalcone E (1) was accomplished for the first time in 13 steps from aryl bromide (6) with 8% overall yield. Palladium-catalyzed Negishi-Reformatsky coupling reaction of compound 6 with ethyl 2-(tributylstannyl)acetate provided the aryl acetic ester (5), which was converted to aryl acetamide (4) via mixed anhydride formation. Chiral auxiliarymediated methylation of the (S)-4-Benzyl-2-oxazolidinone-derived aryl acetamide (4) provided the key asymmetric benzylic methyl group in compound 1.